Apellis Pharmaceuticals (NASDAQ:APLS) Trading Up 5.1% on Analyst Upgrade
Apellis Pharmaceuticals, Inc. (NASDAQ:APLS – Get Free Report) was up 5.1% during trading on Friday after Wedbush raised their price target on the stock from $39.00 to $60.00. Wedbush currently has a neutral rating on the stock. Apellis Pharmaceuticals traded as high as $69.66 and last traded at $69.46. Approximately 966,493 shares traded hands during […]
More Stories
Kavango Resources (LON:KAV) Shares Up 15.3% – Still a Buy?
Kavango Resources Plc (LON:KAV – Get Free Report)’s stock price shot up 15.3% on Monday . The stock traded as...
Highland Copper (CVE:HI) Stock Price Down 17.6% – Time to Sell?
Shares of Highland Copper Company Inc. (CVE:HI – Get Free Report) fell 17.6% on Monday . The stock traded as...
Highland Copper (CVE:HI) Trading Down 17.6% – What’s Next?
Highland Copper Company Inc. (CVE:HI – Get Free Report)’s stock price fell 17.6% on Monday . The company traded as...
National Research Co. (NRC) To Go Ex-Dividend on December 27th
National Research Co. (NASDAQ:NRC – Get Free Report) announced a quarterly dividend on Friday, October 25th,Zacks Dividends reports. Stockholders of...
Directa Plus (LON:DCTA) Sets New 52-Week Low – What’s Next?
Directa Plus Plc (LON:DCTA – Get Free Report) shares hit a new 52-week low on Monday . The stock traded...
Marwyn Value Investors (LON:MVI) Reaches New 1-Year High – Should You Buy?
Marwyn Value Investors (LON:MVI – Get Free Report)’s share price reached a new 52-week high during mid-day trading on Monday...